Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

0.1547
-0.0028-1.78%
Post-market: 0.15550.0008+0.52%19:59 EDT
Volume:131.30M
Turnover:24.05M
Market Cap:75.65M
PE:-0.24
High:0.1695
Open:0.1695
Low:0.1450
Close:0.1575
52wk High:3.87
52wk Low:0.1138
Shares:489.00M
Float Shares:301.00M
Volume Ratio:11.26
T/O Rate:43.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6496
EPS(LYR):-0.7455
ROE:-783.37%
ROA:-62.39%
PB:-0.80
PE(LYR):-0.21

Loading ...

Gossamer Bio announces early tender results, early settlement of solicitation

TIPRANKS
·
Jun 03

Gossamer Bio Reports Early Tender Results for Exchange Offer

MT Newswires Live
·
Jun 03

Gossamer Bio accepts $181.05 million early tenders in convertible notes exchange offer

Reuters
·
Jun 03

Gossamer Bio extends early tender date for exchange offer on 5% convertible notes due 2027

Reuters
·
Jun 02

Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation With Respect to Existing Convertible Notes

THOMSON REUTERS
·
Jun 02

Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), Gossamer Bio (GOSS)

TIPRANKS
·
Jun 01

Investors Sue Gossamer Bio (GOSS) Over Inflated Blood Pressure Study Claims

TIPRANKS
·
May 29

Gossamer Bio Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
May 26

Gossamer Bio Is Maintained at Underweight by Barclays

Dow Jones
·
May 19

Guggenheim Reaffirms Their Hold Rating on Gossamer Bio (GOSS)

TIPRANKS
·
May 19

Gossamer Bio price target lowered to 28c from 30c at Barclays

TIPRANKS
·
May 19

Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and Cullinan Management (CGEM)

TIPRANKS
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

NASD Most Active Issues

Dow Jones
·
May 19

Gossamer Bio launches exchange offer, consent solicitation

TIPRANKS
·
May 18

Gossamer Bio Q1 net loss widens on higher R&D expenses

Reuters
·
May 18

Gossamer Bio launches exchange offer to cut over $120 million debt

Reuters
·
May 18

Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt With Existing Noteholder Support

THOMSON REUTERS
·
May 18

Gossamer Bio Q1 Operating Income USD -44.866 Million

THOMSON REUTERS
·
May 18

Gossamer Bio Q1 EPS USD -0.2

THOMSON REUTERS
·
May 18